Skip to main content
electroCore, Inc. logo

electroCore, Inc. — Investor Relations & Filings

Ticker · ECOR ISIN · US28531P2020 LEI · 5493005O3QC5QV2L2186 US Manufacturing
Filings indexed 453 across all filing types
Latest filing 2022-10-14 Regulatory Filings
Country US United States of America
Listing US ECOR

About electroCore, Inc.

https://www.electrocore.com/

electroCore, Inc. is a commercial-stage bioelectronic medicine company focused on developing and commercializing non-invasive vagus nerve stimulation (nVNS) therapy. The company's proprietary technology platform is designed to treat multiple conditions, primarily in neurology. Its key products, including gammaCore™, are handheld devices that provide a non-invasive method for stimulating the vagus nerve to manage and treat various medical conditions and support general wellness. The company aims to provide innovative solutions for patients suffering from pain and chronic ailments.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings
2022-10-14 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement
2022-10-11 English
PRELIMINARY PROXY STATEMENT
Regulatory Filings
2022-09-30 English
FORM 8-K
Regulatory Filings
2022-09-20 English
10-Q
Interim / Quarterly Report Q2 2022
2022-08-04 English
8-K
Regulatory Filings
2022-08-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.